The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Teva Pharmaceutical Industries Ltd. Abbott Laboratories, Sun Pharmaceuticals Industries Ltd., Mylan N.V. and Pfizer Inc. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

, /PRNewswire/ -- Read the full report: Topical Absorbable Hemostats (Wound Care Management) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within Wound Care Management therapeutic area. The model discusses in detail the impact of COVID-19 on Topical Absorbable Hemostats market for the year 2020 and beyond.Topical hemostatic agents are frequently used in efforts to control bleeding and achieve hemostasis in trauma settings, burn cases and surgical procedures. Surgical procedures vary from cardiovascular, gastrointestinal, obstetrics, and gynecological to other types of surgeries such as orthopedic and peripheral nerve operations. Topical absorbable hemostatic agents, also known as passive hemostats (collagen, gelatin, polysaccharide, oxidized regenerated cellulose and combination hemostats), consist of the integration of an absorbable sponge, foam, pad, or other material with a topical hemostatic agent, which is then applied to the bleeding site. The exact properties of the ideal topical hemostatic agent will vary depending on the surgical specialty, the specific patient population, procedure requirements, the type of bleeding, and the agent's specific mechanism of action. Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes.To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data. Key Inclusions of the market model are - Currently marketed Topical Absorbable Hemostats and evolving competitive landscape - - Insightful review of the key industry trends. - Annualized total Topical Absorbable Hemostats market revenue by segment and market outlooks from 2015-2030. - Granular data on total procedures, units, average selling prices and market values by segment. Global, Regional and Country level market specific insights - - Qualitative market specific information is available with global trends further broken down into regional trends. In addition analysts provide unique country specific insights on the market. - SWOT analysis for Topical Absorbable Hemostats market. - Competitive dynamics insights and trends provided for Topical Absorbable Hemostats market. Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape. - Country specific overview of the healthcare system. - Country specific reimbursement policies. - Country specific medtech regulatory landscape. Robust methodologies and sources enable the model to provide extensive and accurate overview of the market.Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases. Companies covered: Ethicon Inc, C.R. Bard Inc, Baxter International Inc., Pfizer Inc., B. Braun Melsungen AG , Teleflex Incorporated. Countries covered: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , and . This Market Model gives important, expert insight you won't find in any other source. - CMO executives who must have deep understanding of the Topical Absorbable Hemostats marketplace to make strategic planning and investment decisions. - Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management. - Private equity investors that need a deeper understanding of the market to identify and value potential investment targets. The model will enable you to - - Understand the impact of COVID-19 on Topical Absorbable Hemostats market. - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving Topical Absorbable Hemostats market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Topical Absorbable Hemostats market in the future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Track device sales in the global and country-specific Topical Absorbable Hemostats market from 2015-2030. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.Read the full report: About ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare:  US: (339)-368-6001 Intl: +1 339-368-6001

, /PRNewswire/ -- As of this week, over 5 million people have been confirmed to be infected with the virus in alone, with more than 20 million globally. As a result, health care systems are overwhelmed and the effective delivery of medical care to all patients has become a challenge worldwide. Among the many factors that had likely affected the spread of the disease are inadequate attention to early warning signs, insufficient stockpiling, lack of access to testing kits and personal protective equipment (PPE), and nationwide variability in the approaches to testing and distribution of PPE. Of course, medical device companies have not escaped the pandemic's impact. Similar to biotech companies, medical device makers count on healthcare facilities for their clinical trial data collection. Nemaura Medical, Inc. (NASDAQ: NMRD), FLIR Systems, Inc. (NASDAQ: FLIR), Johnson & Johnson (NYSE: JNJ), iBio, Inc. (NYSE: IBIO), Pfizer Inc. (NASDAQ: PFE).